| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 3 |
| 1 | METHOTREXATE | 3 |
| 2 | METHOTREXATE SODIUM | 3 |
| 3 | ALENDRONATE SODIUM | 2 |
| 4 | BOTULINUM TOXIN TYPE A | 2 |
| 5 | CYCLOSPORINE | 2 |
| 6 | DAPSONE | 2 |
| 7 | DAPSONE GEL, 5% | 2 |
| 8 | DASPONE | 2 |
| 9 | EFAVIRENZ | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMINOLEVULINIC ACID HYDROCHLORIDE | 1 | 0.0006 |
| 1 | PRALSETINIB | 1 | 0.0005 |
| 2 | NEVIRAPINE | 2 | 0.0002 |
| 3 | CARMUSTINE | 1 | 0.0002 |
| 4 | DASPONE | 2 | 0.0002 |
| 5 | DAPSONE GEL, 5% | 2 | 0.0002 |
| 6 | DAPSONE | 2 | 0.0002 |
| 7 | EFAVIRENZ | 2 | 0.0002 |
| 8 | BOTULINUM TOXIN TYPE A | 2 | 0.0002 |
| 9 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfone [EPC] | 2 | 0.0002 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 3 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 4 | Acetylcholine Release Inhibitor [EPC] | 4 | 0.0000 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 2 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 2 | 0.0000 |
| 8 | Prostaglandin Analog [EPC] | 1 | 0.0000 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |